The RSA Group, a leading life sciences executive search firm, is pleased to announce the appointment of Jason McKenna as CEO at Prescient Healthcare Group – a leading biopharma product and portfolio strategy firm. Jason will start his new position on 6th January 2025.

With over two decades of experience in the pharmaceutical and healthcare industries, Jason brings an impressive track record of leadership and growth. Jason began his career at AstraZeneca, where he built up experience in marketing, sales and finance across the US and UK markets. After that, he went on to found STEM Healthcare (STEM) in the US and Brazil, transitioning from the client side to the service side of the industry.

After leading STEM through a significant growth phase, he played a key role in the company’s acquisition by UDG Healthcare in 2016 and then guided the business through the challenges of the COVID-19 pandemic. Private equity firm Clayton, Dubilier & Rice acquired UDG Healthcare in 2021, renaming it Inizio. Jason assumed a new leadership position at Inizio, establishing the company’s biotech business unit in 2022. He most recently held the position of Chief Growth Officer of Inizio Engage, where he was responsible for managing global sales and marketing across five specialty areas.

Nick Stephens, Executive Chairman of RSA, commented: “The RSA team, including myself, Jamie Gould and Ollie Stephens, has greatly enjoyed working with Prescient Healthcare Group to support them in delivering their growth plans through global searches such as this. Jason’s wealth of experience in strong leadership and driving growth made him an excellent candidate for this position. We wish him every success in his new role.”

ENDS

For further information, contact:
Nick Stephens
Executive Chairman, The RSA Group
E: Nick.Stephens@theRSAgroup.com

Notes to Editors

About The RSA Group
Founded in 1981, we are the pre-eminent global executive search firm in Life Sciences and Healthcare. We provide a unique combination of Executive Search and Executive Interims from Director to Board Level. In addition to supporting clients with market due diligence, competitor benchmarking, and brand perception surveys, we also review organisations as part of our People & Organisation Advisory and recommend the best options for evolution across organisational design, talent acquisition, development, and succession planning. With offices globally, we offer clients and candidates alike our in-depth knowledge and understanding of the life sciences industry, as well as first class project execution. To learn more about The RSA Group, visit www.theRSAgroup.com.

Share this: